InspireMD (NYSE:NSPR) this week announced it appointed Andrea Tommasoli as chief operating officer. Tommasoli was previously the company’s senior VP of global sales and marketing since November 2020. Prior to joining InspireMD, Tommasoli was most recently the senior sales director of indirect markets at Integra Lifesciences. “Andrea has been instrumental in expanding the footprint of CGuard […]
InspireMD
InspireMD grows sales 33% in Q3
InspireMD (NYSE:NSPR) this week posted third-quarter results that beat the overall consensus on Wall Street. The Tel Aviv, Israel-based company reported net losses of $4.5 million, or -58¢ per share, on sales of $1.43 million for the three months ended Sept. 30, for a sales growth of 33.61% compared with Q3 2021. Earnings per share […]
InspireMD sales up 231% in mixed-bag Q2 results
InspireMD (NYSE:NSPR) posted second-quarter results this week that beat the earnings consensus on Wall Street but missed revenue estimates. The Tel Aviv, Israel-based carotid stenting company reported losses of $3.5 million, or -46¢ per share, on sales of $1.03 million for the three months ended June 30, for a sales growth of 231.63% compared with Q2 […]
InspireMD dips despite Street-beating Q1
InspireMD (NYSE:NSPR) shares slid today despite first-quarter results that topped the consensus forecast. The Tel Aviv, Israel-based company posted losses of -$3.2 million, or -53¢ per share, on sales of $1 million for the three months ended March 31, 2021, for a -64% bottom-line slide on a sales decline of -2.7%. InspireMD’s EPS of -53¢ […]
InspireMD wins FDA approval for carotid stent system study
InspireMD today said it received FDA approval to proceed with a pivotal study of its CGuard Carotid Stent System. The investigational device exemption from the FDA will allow the company to study the device for the prevention of stroke in patients in the U.S. Get the full story on our sister site, Medical Tubing + […]
InspireMD posts Street-beating Q2 results
InspireMD (NYSE:NSPR) posted second-quarter results today that beat the consensus on Wall Street. The Tel Aviv, Israel-based company reported losses of $2.5 million, on sales of $313,000 for the three months ended June 30, for a sales loss of -76.9% compared with Q2 2019. Earnings per share were -20¢, 15¢ ahead of The Street, where analysts […]
InspireMD raises $10.7m
InspireMD (NYSE:NSPR) announced today that it entered into an underwriting agreement to raise $10.7 million. According to a news release, InspireMD entered into the underwriting agreement on June 3 with A.G.P./Alliance Global Partners in the offering of more than 7.6 million units consisting of one share of InspireMD’s common stock and one Series F warrant to […]
Barry out as InspireMD CEO
InspireMD (NYSE:NSPR) announced today that president & CEO James Barry is stepping down, effective Dec. 31, to pursue other opportunities. InspireMD is facing a potential de-listing from the New York Stock Exchange after reporting stockholders’ equity of less than $6 million as of June 30 and net losses for the last five years. The company […]
Eko raises $20m Series B for smart cardiac monitor | Funding Roundup, September 26, 2019
Eko said yesterday that it raised a $20 million Series B round for the smart cardiac monitor it’s developing. The San Francisco-based company is working on machine learning technology for a combined digital stethoscope and electrocardiogram, designed for both clinical and at-home monitoring. Eko said more than 3,000 hospitals worldwide use its platform, treating millions […]
InspireMD registers $6m offering
InspireMD (NYSE:NSPR) last week registered for an offering worth more than $6 million for its MicroNet stent platform. MicroNet is a micron mesh sleeve that’s designed to wrap a stent and provide embolic protection in the treatment of complex vascular and coronary disease. InspireMD used the platform to develop the CGuard carotid embolic prevention system, […]
InspireMD pulls the trigger on another reverse stock split
InspireMD (NYSE:NSPR) said this week its stockholders approved a 1-for-50 reverse split of its stock, slated to take effect today. The reverse split comes only 13 months after its last 1-for-35 reverse split, which the Israel-based company initiated last February. Through the deal, each shareholder in the company will receive a single share of the company’s […]